Citadel Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.14M | Sell |
|
|||||
|
2025
Q2 | $9.09M | Buy |
|
|||||
|
2025
Q1 | $4.75M | Sell |
|
|||||
|
2024
Q4 | $10.5M | Buy |
|
|||||
|
2024
Q3 | $1.86M | Sell |
|
|||||
|
2024
Q2 | $43.1M | Buy |
|
|||||
|
2024
Q1 | $29.1M | Buy |
|
|||||
|
2023
Q4 | $22.3M | Buy |
|
|||||
|
2023
Q3 | $10.8M | Buy |
|
|||||
|
2023
Q2 | $876K | Buy |
|
|||||
|
2023
Q1 | $49.8K | Sell |
|
|||||
|
2022
Q4 | $482K | Buy |
|
|||||
|
2022
Q3 | – | Hold |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.08M | Sell |
|
|||||
|
2021
Q4 | $1.49M | Sell |
|
|||||
|
2021
Q3 | $2.38M | Sell |
|
|||||
|
2021
Q2 | $4.52M | Sell |
|
|||||
|
2021
Q1 | $4.82M | Buy |
|
|||||
|
2020
Q4 | $638K | Sell |
|
|||||
|
2020
Q3 | $493K | Buy |
|
|||||
|
2020
Q2 | $381K | Sell |
|
|||||
|
2020
Q1 | $1.14M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $961K | Sell |
|
|||||
|
2019
Q2 | $4.95M | Sell |
|
|||||
|
2019
Q1 | $7.84M | Sell |
|
|||||
|
2018
Q4 | $8.8M | Buy |
|
|||||
|
2018
Q3 | $10.1M | Buy |
|
|||||
|
2018
Q2 | $3.04M | Buy |
|
|||||
|
2018
Q1 | $734K | Sell |
|
|||||
|
2017
Q4 | $1.84M | Buy |
|
|||||
|
2017
Q3 | $532K | Buy |
|
|||||
|
2017
Q2 | $296K | Sell |
|
|||||
|
2017
Q1 | $2.16M | Sell |
|
|||||
|
2016
Q4 | $7.14M | Sell |
|
|||||
|
2016
Q3 | $28.2M | Buy |
|
|||||
|
2016
Q2 | $4.04M | Sell |
|
|||||
|
2016
Q1 | $5.58M | Buy |
|
|||||
|
2015
Q4 | $349K | Sell |
|
|||||
|
2015
Q3 | $399K | Buy |
|
|||||
|
2015
Q2 | $338K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $93K | Buy |
|
|||||
|
2014
Q3 | $103K | Sell |
|
|||||
|
2014
Q2 | $723K | Sell |
|
|||||
|
2014
Q1 | $2.43M | Sell |
|
|||||
|
2013
Q4 | $4.72M | Sell |
|
|||||
|
2013
Q3 | $8.26M | Buy |
|
|||||
|
2013
Q2 | $1.38M | Buy |
|